Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

MHealth Intervention of HIV and STDs Partner Notification for MSM

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04349748
Recruitment Status : Not yet recruiting
First Posted : April 16, 2020
Last Update Posted : May 27, 2020
Sponsor:
Collaborator:
Man Wellness Center, Beijing, China
Information provided by (Responsible Party):
ZhongweiJia, National Institute on Drug Dependence, China

Brief Summary:
Men who have sex with men (MSM) have become a focus of HIV and other sexually transmitted diseases (STD) control in China. Most of MSM who seek causal partners through online dating platforms do not know their sexual partners' real HIV and STDs infection status, which leads to more high risk status, especially for sexual behaviors. Effective Internet-based partner notification is urgently warranted to increase their risk awareness and prevent HIV and STDs transmission. This study developed an app which can help MSM to query recent HIV and other STDs statuses each other from the testing platform in order that they can find a relatively safety sexual partners and reduce risk of HIV infection.

Condition or disease Intervention/treatment Phase
HIV/AIDS Sexually Transmitted Diseases Prevention Behavioral: Health education, and regular HIV and STDs testing prompting service Behavioral: Health status inquiry through app (partner notification) Not Applicable

Detailed Description:
Because most of the recent "Partner Notification" methods are a kind of afterwards remedial measures and will fail to find some of the infected MSM, researchers propose a preventive measures before they meet together. For MSM who are seeking potential sexual partners through Internet, researchers will encourage them to query health status before they decide to meet each other in order to promote their healthy self-responsibility consciousnes including avoiding HIV and other STDs infection, which will form a real ,digital MSM cohort. Researchers designed a pragmatic stepped wedge cluster randomized controlled trial to evaluate the effect of an intervention paradigm that provides HIV, syphilis, hepatitis B, and hepatitis C status partner notification based on the existing HIV and STDs control methods through an mHealth application (app), to reduce HIV and STDs incidences among MSM in China. More than 6000 MSM of 16 districts in Beijing, China will be grouped into four arms, each arm will cover four indepednent districts of Beijing randomly. The four arms will be randomized to sequentially initiate partner notification intervention through the app at 6-month intervals. All participants will be provided informed consent in the app after a full explanation of the protocol design. Researchers expect that the HIV incidence will be significantly lower and the secondary outcomes will also be better after partner notification intervention. The feasible and affordable public health management paradigm will have implications for HIV and STDs prevention and control among MSM and other key populations.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 6172 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: This study is not a conventional crossover design,we use a pragmatic stepped-wedge cluster-randomised design.The study lasts for 2.5 years, which is divided to five continuous observation periods (every six months).The sixteen districts are assigned to four arms randomly.Four arms began recruiting participants at the same time,and at the first observation period,all groups were given health education and regular HIV and STDs testing prompting service,the two services above are given continuously for five observation periods.At the second observation period,the first group is given permission to query health status (partner notification) through app,but the other three groups do not.At every observation period after that (the third to fifth observation period),the three groups will be given permission to query health status one by one.Once a group is given the permission,it is retained until the end of study.
Masking: Single (Outcomes Assessor)
Masking Description: Because partner notification is a kind of behavioral intervention, participants know what intervention they receive. However, we take efforts to reduce the bias caused by the non-blind design. At the beginning of the research, participants, care providers, and researchers who participate in participants management will not know the randomized scheme. The partner notification will be opened to participants sequentially by the predetermined computer program, and does not need care providers and researchers to implement the intervention manually. The care providers and researchers do not know the implementation of partner notification unless the participants tell them whether they can use the function on their own initiative. Even the care providers know that, the operation and results of the HIV and STDs testing will not be affected. At last, the outcomes assessors do not know the randomized scheme in data analysis.
Primary Purpose: Prevention
Official Title: The Effect of Providing mHealth Intervention of Partner Notification to Protect MSM From HIV and Sexually Transmitted Diseases Infection: a Pragmatic Stepped Wedge Cluster Randomized Controlled Trial
Estimated Study Start Date : July 1, 2020
Estimated Primary Completion Date : December 31, 2022
Estimated Study Completion Date : June 30, 2023

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Group 1
The group is given health education, regular HIV and STDs testing prompting service in the whole study, and permission to query health status (partner notification) through app from the second observation period. HIV and STDs testing and questionnaire are given to the participants when they receive the testing service.
Behavioral: Health education, and regular HIV and STDs testing prompting service
Health education through app for once a week, and regular HIV and STDs testing prompting service (every month through app) are given to the participants at the beginning of the study and last for the whole five observation periods.

Behavioral: Health status inquiry through app (partner notification)
The permission to query health status through app (partner notification) is given to participants (participants can query their potential sexual partner's status of HIV, syphilis, hepatitis B, and hepatitis C respectively through app) at the specific observation period,and the permission is retained until the end of study.

Experimental: Group 2
The group is given health education, regular HIV and STDs testing prompting service in the whole study, and permission to query health status (partner notification) through app from the third observation period. HIV and STDs testing and questionnaire are given to the participants when they receive the testing service.
Behavioral: Health education, and regular HIV and STDs testing prompting service
Health education through app for once a week, and regular HIV and STDs testing prompting service (every month through app) are given to the participants at the beginning of the study and last for the whole five observation periods.

Behavioral: Health status inquiry through app (partner notification)
The permission to query health status through app (partner notification) is given to participants (participants can query their potential sexual partner's status of HIV, syphilis, hepatitis B, and hepatitis C respectively through app) at the specific observation period,and the permission is retained until the end of study.

Experimental: Group 3
The group is given health education, regular HIV and STDs testing prompting service in the whole study, and permission to query health status (partner notification) through app from the fourth observation period. HIV and STDs testing and questionnaire are given to the participants when they receive the testing service.
Behavioral: Health education, and regular HIV and STDs testing prompting service
Health education through app for once a week, and regular HIV and STDs testing prompting service (every month through app) are given to the participants at the beginning of the study and last for the whole five observation periods.

Behavioral: Health status inquiry through app (partner notification)
The permission to query health status through app (partner notification) is given to participants (participants can query their potential sexual partner's status of HIV, syphilis, hepatitis B, and hepatitis C respectively through app) at the specific observation period,and the permission is retained until the end of study.

Experimental: Group 4
The group is given health education, regular HIV and STDs testing prompting service in the whole study, and permission to query health status (partner notification) through app from the fifth observation period. HIV and STDs testing and questionnaire are given to the participants when they receive the testing service.
Behavioral: Health education, and regular HIV and STDs testing prompting service
Health education through app for once a week, and regular HIV and STDs testing prompting service (every month through app) are given to the participants at the beginning of the study and last for the whole five observation periods.

Behavioral: Health status inquiry through app (partner notification)
The permission to query health status through app (partner notification) is given to participants (participants can query their potential sexual partner's status of HIV, syphilis, hepatitis B, and hepatitis C respectively through app) at the specific observation period,and the permission is retained until the end of study.




Primary Outcome Measures :
  1. HIV positive seroconversion rate (HIV incidence) [ Time Frame: through study completion, an average of six months ]
    The number of HIV positive seroconversions divided by the total number of person-years.

  2. Additional cost of the intervention [ Time Frame: through study completion, an average of six months ]
    The total cost and average cost for per participant of the integrated intervention model and each additional intervention/service based on the existing HIV prevention measures provided as before.


Secondary Outcome Measures :
  1. Syphilis positive seroconversion rate (Syphilis incidence) [ Time Frame: through study completion, an average of six months ]
    The number of syphilis seroconversions divided by the total number of person-years.

  2. Hepatitis B positive seroconversion rate (Hepatitis B incidence) [ Time Frame: through study completion, an average of six months ]
    The number of hepatitis B seroconversions divided by the total number of person-years.

  3. Hepatitis C positive seroconversion rate (Hepatitis C incidence) [ Time Frame: through study completion, an average of six months ]
    The number of hepatitis C seroconversions divided by the total number of person-years.

  4. HIV and related diseases transmission among social networks [ Time Frame: through study completion, an average of 1 year ]
    Based on the partner notification information, we will construct the transmission networks of HIV and other STDs (syphilis, hepatitis B, and hepatitis C) among participants, and analyze the characteristics of these networks and factors associated with transmission of these diseases.

  5. Testing adherence [ Time Frame: through study completion, an average of 1 year ]
    The proportion of participants whose every adjacent testing interval is no more than 3 months as recommended by China CDC.

  6. Additional cost for finding per seroconversion [ Time Frame: through study completion, an average of six months ]
    The total additional cost of the integrated intervention model based on the existing HIV prevention measures provided as before divided by the total number of the HIV and STDs seroconversions.

  7. Frequency of utilization for each intervention/service [ Time Frame: through study completion, an average of six months ]
    The total frequency and average frequency for per participant of utilization for each intervention/service, such as health education, partner notification, HIV and STDs testing and so on.

  8. Satisfaction of the interventions and services [ Time Frame: through study completion, an average of six months ]
    This indicator is measured by the follow-up questionnaires as the degree of satisfaction for participants of HIV and STDs testing service, health education, partner notification and other app's functions.

  9. Knowledge of HIV and related STDs [ Time Frame: through study completion, an average of six months ]
    This indicator is measured by the baseline and follow-up questionnaires, and we use the score of knowledge questions in the questionnaires to represent participants' level of knowledge.

  10. Attitudes of HIV and STDs testing, safe sexual behaviors and partner notification [ Time Frame: through study completion, an average of six months ]
    The attitudes are collected by these questions in the baseline and follow-up questionnaires.

  11. Sexual behaviors [ Time Frame: through study completion, an average of six months ]
    They are measured by questionnaires, including questions about the number of different kinds of sexual partners, frequency of anal sex, condom use, and partner notification implementation.

  12. Substance use behaviors [ Time Frame: through study completion, an average of six months ]
    This indicator is measured by questionnaires about participants' usage about methamphetamine, heroin, ecstasy, and some other sex-promoting drugs.

  13. Psychological status [ Time Frame: through study completion, an average of six months ]
    SAS (self-rating anxiety) scale and SDS (self-rating depression) scale are used to measure participants' psychological status through questionnaires. The higher scores of the two scares mean the worse outcomes.

  14. Referral rate of HIV and related STDs [ Time Frame: through study completion, an average of six months ]
    The proportion of new HIV and STDs infections who have received treatment.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion criteria:

  1. biologically male,
  2. had oral or anal sex with men at least once during their lifetime,
  3. 15 years of age or older,
  4. had no difficulty using a mobile phone,
  5. willing to provide their mobile phone numbers to serve as the unique identification numbers of the app's self-query and partner notification functions,
  6. willing to use the app's function modules,
  7. willing to complete the questionnaire for the research,
  8. willing to continuously receive HIV and STDs testing and consulting services provided by the CBO our research setting at,
  9. willing to complete the informed consent document.

Exclusion criteria:

1.had serious physical disabilities or mental diseases.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04349748


Contacts
Layout table for location contacts
Contact: Zhongwei Jia, Prof. PhD +86-10-82802457 urchinjj@163.com
Contact: Xiangyu Yan, PhD +86-18380205261 yanxiangyu@bjmu.edu.cn

Sponsors and Collaborators
National Institute on Drug Dependence, China
Man Wellness Center, Beijing, China
Investigators
Layout table for investigator information
Principal Investigator: Zhongwei Jia, Prof. PhD National Institute on Drug Dependence, Peking University,China
Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: ZhongweiJia, Professor, Director of Center for Drug Abuse Control and Prevention, National Institute on Drug Dependence, China
ClinicalTrials.gov Identifier: NCT04349748    
Other Study ID Numbers: NIDD-HIV
First Posted: April 16, 2020    Key Record Dates
Last Update Posted: May 27, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description:
  1. Study Protocol,part of study report and data will be published in journals;
  2. Researchers can contact the principal investigator(PI:ZhongweiJia) for IPD through email two years after the end of the trial.
Supporting Materials: Study Protocol
Statistical Analysis Plan (SAP)
Informed Consent Form (ICF)
Clinical Study Report (CSR)
Analytic Code
Time Frame: Two years after the end of the trial
Access Criteria: Data applicants should send email to PI. Real personal basic information (name, unit, title, etc.), detailed description of required data (required variables,etc.), and research plan should be included in the email. Our team will discuss the research proposal and reply as soon as possible

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by ZhongweiJia, National Institute on Drug Dependence, China:
HIV/AIDS
sexually transmitted disease (STD)
men who have sex with men (MSM)
partner notification
mHealth application
stepped wedge cluster randomized controlled trial
Additional relevant MeSH terms:
Layout table for MeSH terms
Acquired Immunodeficiency Syndrome
HIV Infections
Sexually Transmitted Diseases
Blood-Borne Infections
Communicable Diseases
Infections
Sexually Transmitted Diseases, Viral
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
Slow Virus Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Disease Attributes
Pathologic Processes